Jon C. Ogg
All articles

Everything by Jon.

17,999 articles

← Back to profile
Services

Will Airline Miles and Hotel Points Be Groupon’s Next Growth Driver?

Oct 25, 2017
Investing

Top Analyst Upgrades and Downgrades: AMD, Apple, Biogen, Capital One, Chipotle, GM, 3M and More

Oct 25, 2017
Investing

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Oct 24, 2017
Investing

Top Analyst Upgrades and Downgrades: Boston Scientific, Cleveland-Cliffs, GE, Hasbro, Illumina, T-Mobile, United Continental, Seagate and More

Oct 24, 2017
Technology

What Cisco Really Gets With the Acquisition of BroadSoft

Oct 23, 2017
Economy

Chicago Fed Shows National Economic Activity Rebounded in September

Oct 23, 2017
Investing

Top Analyst Upgrades and Downgrades: Biogen, Equifax, Foot Locker, GE, NVIDIA, Rio Tinto, Roku and More

Oct 23, 2017
Investing

10 Speculative Analyst Stocks With Huge Potential Upside

Oct 21, 2017
Industrials

10 Harsh Realities GE Shareholders Will Have to Face From 2018 to 2020

Oct 21, 2017
Investing

Top Analyst Upgrades and Downgrades: Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal, Stratasys and More

Oct 20, 2017
Health and Healthcare

Does Gilead’s CAR T Approval Vindicate the High Acquisition Price for Kite Pharma?

Oct 19, 2017
Economy

Jobless Claims Hit Lowest Levels Since 1973

Oct 19, 2017
Economy

Leading Indicators Post First Drop in Over a Year

Oct 19, 2017
Investing

Top Analyst Upgrades and Downgrades: Adobe, Allergan, Amex, Baker Hughes, Nike, Northern Dynasty, Sprint, Wayfair and More

Oct 19, 2017
Investing

Forget DJIA 23,000 — Why DJIA 25,000 May Be in the Cards for 2018

Oct 18, 2017
Energy

Exxon Mobil Expands With Permian Basin Terminal Acquisition

Oct 18, 2017
Health and Healthcare

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

Oct 18, 2017
Investing

Meet the New ETF Using Artificial Intelligence to Pick Stocks to Buy

Oct 18, 2017
Technology

IBM Earnings Dilemma: Are Analysts Missing the Boat After 22 Quarters of Revenue Decline?

Oct 18, 2017
Health and Healthcare

Analysts Piling On to Raise Johnson & Johnson Price Targets Higher and Higher

Oct 18, 2017